Asarina Pharma AB (publ) (ASAP.ST)
SEK 0.03
(-31.03%)
SEK 0.03
(-31.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 423 Thousand | 406 Thousand | 388 Thousand | 89 Thousand | - | - |
| Gross Profit | -423 Thousand | -406 Thousand | -388 Thousand | -89 Thousand | - | - |
| Operating Expenses | 14.65 Million | 14.68 Million | 38.28 Million | 81.4 Million | 81.23 Million | 51.59 Million |
| Selling, General and Administrative Expenses | 7.72 Million | 3.08 Million | 2.9 Million | 7.44 Million | 5.89 Million | 6.19 Million |
| Research and Development Expenses | 6.49 Million | 7.29 Million | 29.92 Million | 63.74 Million | 63.44 Million | 39.03 Million |
| Other Expenses | - | 4.3 Million | 5.45 Million | 10.21 Million | 11.89 Million | 6.37 Million |
| Cost and Expenses | 14.65 Million | 14.68 Million | 38.28 Million | 81.4 Million | 81.23 Million | 51.59 Million |
| Operating Income | -14.64 Million | -14.68 Million | -38.28 Million | -81.4 Million | -81.03 Million | -51.59 Million |
| Interest Expense | - | 298 Thousand | 395 Thousand | 201 Thousand | 252 Thousand | 171 Thousand |
| Income Tax Expense | 1.75 Million | -1.54 Million | -6.63 Million | -7.73 Million | -7.8 Million | -7.56 Million |
| Earnings before Tax | -14.57 Million | -14.82 Million | -38.29 Million | -82.99 Million | -78.87 Million | -51.59 Million |
| Net Income | -12.82 Million | -13.28 Million | -31.65 Million | -75.25 Million | -71.07 Million | -44.02 Million |
| Earnings Per Share Basic | -0.57 | -0.71 | -1.69 | -4.02 | -4.30 | -2.75 |
| Earnings Per Share Diluted | -0.57 | -0.71 | -1.69 | -4.02 | -4.30 | -2.75 |
| Weighted Average Shares Outstanding | 22.64 Million | 18.78 Million | 18.74 Million | 18.7 Million | 16.53 Million | 16.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.64 Million | 18.78 Million | 18.74 Million | 18.7 Million | 16.53 Million | 16.03 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -14.21 Million | -14.12 Million | -37.89 Million | -82.7 Million | -81.48 Million | -51.42 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | 423 Thousand | - | - | - | - |
| Gross Profit | - | -423 Thousand | - | - | - | - |
| Operating Expenses | 2.56 Million | 14.21 Million | 2.56 Million | 4.76 Million | 4.76 Million | 3.26 Million |
| Selling, General and Administrative Expenses | 2.03 Million | - | 2.03 Million | 1.83 Million | 1.83 Million | 1.84 Million |
| Research and Development Expenses | 424.5 Thousand | - | 424.5 Thousand | 2.82 Million | 2.82 Million | 1.38 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 2.56 Million | 14.64 Million | 2.56 Million | 4.76 Million | 4.76 Million | 3.26 Million |
| Operating Income | -2.55 Million | -14.64 Million | -2.55 Million | -4.76 Million | -4.76 Million | -3.34 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 875 Thousand | -1.75 Million | 875 Thousand | - | - | 772.5 Thousand |
| Earnings before Tax | -2.54 Million | -14.57 Million | -2.54 Million | -4.74 Million | -4.74 Million | -3.31 Million |
| Net Income | -1.67 Million | -12.82 Million | -1.67 Million | -4.74 Million | -4.74 Million | -2.54 Million |
| Earnings Per Share Basic | -0.07 | - | -0.07 | -0.21 | -0.21 | -0.14 |
| Earnings Per Share Diluted | -0.07 | - | -0.07 | -0.21 | -0.21 | -0.14 |
| Weighted Average Shares Outstanding | 22.64 Million | 22.64 Million | 22.64 Million | 22.64 Million | 22.64 Million | 18.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.64 Million | 22.64 Million | 22.64 Million | 22.64 Million | 22.64 Million | 18.78 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -2.45 Million | - | -2.45 Million | -4.65 Million | -4.65 Million | -3.23 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
EPBIO
API
688113
301004
DAVA
322000